Announcements
- IMMUPHARMA AT BIO-EQUITY 2024 12-14 May
- Grant of Share Options
- New intellectual property strategy initiated
- Incanthera provides Comm'l Update/Revenue F'casts
- Grant of Share Options
- IMMUPHARMA AT BIO-EUROPE SPRING 2024
- Financial, Business and Portfolio Develop't Update
- Holding(s) in Company
- Simbec-Orion appointed as CRO
- Incanthera - Comm'l Skincare Deal/£1M Fundraise
More ▼
Key statistics
On Thursday, ImmuPharma PLC (25I:FRA) closed at 0.02, 9,900.00% above the 52 week low of 0.0002 set on Feb 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.02 |
---|---|
High | 0.02 |
Low | 0.02 |
Bid | 0.014 |
Offer | 0.044 |
Previous close | 0.021 |
Average volume | 0.00 |
---|---|
Shares outstanding | 416.44m |
Free float | 237.37m |
P/E (TTM) | -- |
Market cap | 8.47m GBP |
EPS (TTM) | -0.0092 GBP |
Data delayed at least 15 minutes, as of May 02 2024 08:17 BST.
More ▼